Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Local alpha-1 antitrypsin for donor-site healing after split-thickness skin grafting
MOH_2023-06-25_012766Phase 2Not yet recruiting
- Sponsor
- פרופסור אלדד זילברשטין
- Start
- Jun 2023
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, open-label trial of alpha-1-proteinase inhibitor in cutaneous wound (2 arms), sponsored by פרופסור אלדד זילברשטין. Primary endpoint: Wound healing and time to wound closure. Planned start Jun 2023; status: not yet recruiting.
02
Drugs
alpha-1-proteinase inhibitor
03
Conditions
cutaneous wound
Beyond the preview
Go deeper on MOH_2023-06-25_012766.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on MOH_2023-06-25_012766.